OPRX logo

OptimizeRx (OPRX) Cash From Operations

Annual CFO

-$7.24 M
-$17.89 M-167.95%

December 31, 2023

Summary

Performance

1-Year Change

-167.95%

3-Year Change

-14.72%

5-Year Change

-1013.35%

15-Year Change

-389.2%

OPRX Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

63.4%
OPRX annual cash flow from operations is higher than 63.4% of companies in Healthcare sector

High & Low

All-time High

$10.65 M
OPRX annual cash flow from operations is currently -167.95% below its historical high of $10.65 million

3-Year Low

-$7.24 M
OPRX annual cash flow from operations is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OPRX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 12, 2025
OPRX next annual earnings announcement is scheduled for Mar 12, 2025

OtherOPRXcash flowmetrics:

Annual CFI

-$25.34 M
OPRX annual cash flow from investing activities is -$25.34 million

Annual CFF

$28.22 M
OPRX annual cash flow from financing activities is $28.22 million

Annual FCF

-$8.11 M
OPRX annual free cash flow is -$8.11 million

Annual CAPEX

$871.40 K
OPRX annual capital expenditures is $871.40 thousand

Quarterly CFO

$1.79 M
+$1.01 M+129.03%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+234.21%

5-Year Change

+219.41%

OPRX Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

76.46%
OPRX quarterly cash flow from operations is higher than 76.46% of companies in Healthcare sector

High & Low

All-time High

$4.08 M
OPRX quarterly cash flow from operations is currently -56.11% below its historical high of $4.08 million

3-Year Low

-$6.26 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
OPRX next earnings announcement is scheduled for Mar 12, 2025

OtherOPRXcash flowmetrics:

Quarterly CFI

-$92.00 K
OPRX quarterly cash flow from investing activities is -$92.00 thousand

Quarterly CFF

-$532.00 K
OPRX quarterly cash flow from financing activities is -$532.00 thousand

Quarterly FCF

$1.70 M
OPRX quarterly free cash flow is $1.70 million

Quarterly CAPEX

$92.00 K
OPRX quarterly capital expenditures is $92.00 thousand

TTM CFO

-$1.57 M
+$318.00 K+16.88%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-315.7%

5-Year Change

+5.7%

OPRX TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

73.19%
OPRX TTM cash flow from operations is higher than 73.19% of companies in Healthcare sector

High & Low

All-time High

$10.65 M
OPRX TTM cash flow from operations is currently -114.70% below its historical high of $10.65 million

3-Year Low

-$7.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OPRX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 12, 2025
OPRX next earnings announcement is scheduled for Mar 12, 2025

OtherOPRXcash flowmetrics:

TTM CFI

-$26.33 M
OPRX TTM cash flow from investing activities is -$26.33 million

TTM CFF

$34.10 M
OPRX TTM cash flow from financing activities is $34.10 million

TTM FCF

-$1.12 M
OPRX TTM free cash flow is -$1.12 million

TTM CAPEX

-$445.60 K
OPRX TTM capital expenditures is -$445.60 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

OPRX Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-167.9%0.0%0.0%
3 y3 years-14.7%+234.2%-315.7%
5 y5 years-1013.4%+219.4%+5.7%

OPRX Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-167.9%at low-56.1%+128.6%-114.7%+78.4%
5 y5-year-167.9%at low-56.1%+128.6%-114.7%+78.4%
alltimeall time-167.9%at low-56.1%+128.6%-114.7%+78.4%

OptimizeRx Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$1.79 M(+129.0%)
-$1.57 M(-16.9%)
Jun 2024
-
$782.00 K(-63.1%)
-$1.88 M(-62.6%)
Mar 2024
-
$2.12 M(-133.8%)
-$5.04 M(-30.4%)
Dec 2023
-$7.24 M(-167.9%)
-$6.26 M(-524.8%)
-$7.24 M(-497.4%)
Sep 2023
-
$1.47 M(-162.2%)
$1.82 M(-52.2%)
Jun 2023
-
-$2.37 M(+2654.7%)
$3.81 M(-41.3%)
Mar 2023
-
-$86.00 K(-103.1%)
$6.49 M(-39.1%)
Dec 2022
$10.65 M(+1367.5%)
$2.80 M(-19.0%)
$10.65 M(+63.5%)
Sep 2022
-
$3.46 M(+1023.7%)
$6.52 M(+100.0%)
Jun 2022
-
$308.10 K(-92.4%)
$3.26 M(+3.8%)
Mar 2022
-
$4.08 M(-405.7%)
$3.14 M(+332.5%)
Dec 2021
$726.00 K(-111.5%)
-$1.33 M(-751.3%)
$726.10 K(-236.5%)
Sep 2021
-
$204.90 K(+7.9%)
-$532.00 K(-36.9%)
Jun 2021
-
$189.90 K(-88.6%)
-$843.50 K(-6.9%)
Mar 2021
-
$1.67 M(-164.3%)
-$905.80 K(-85.6%)
Dec 2020
-$6.31 M(+280.0%)
-$2.59 M(+2332.1%)
-$6.31 M(+20.9%)
Sep 2020
-
-$106.60 K(-183.5%)
-$5.22 M(-14.2%)
Jun 2020
-
$127.60 K(-103.4%)
-$6.08 M(-3.3%)
Mar 2020
-
-$3.74 M(+149.3%)
-$6.29 M(+278.7%)
Dec 2019
-$1.66 M(-309.5%)
-$1.50 M(+54.8%)
-$1.66 M(-315.2%)
Sep 2019
-
-$969.10 K(+1084.7%)
$771.90 K(-72.6%)
Jun 2019
-
-$81.80 K(-109.2%)
$2.82 M(+14.2%)
Mar 2019
-
$890.00 K(-4.6%)
$2.47 M(+211.6%)
Dec 2018
$792.60 K(-153.6%)
$932.80 K(-13.5%)
$792.60 K(-687.1%)
Sep 2018
-
$1.08 M(-350.0%)
-$135.00 K(-93.3%)
Jun 2018
-
-$431.50 K(-45.2%)
-$2.00 M(+1.7%)
Mar 2018
-
-$787.40 K(<-9900.0%)
-$1.97 M(+33.1%)
Dec 2017
-$1.48 M(+217.6%)
$5200.00(-100.7%)
-$1.48 M(-22.1%)
Sep 2017
-
-$788.90 K(+97.8%)
-$1.90 M(+93.0%)
Jun 2017
-
-$398.90 K(+34.2%)
-$984.60 K(+106.4%)
Mar 2017
-
-$297.20 K(-28.5%)
-$477.00 K(+2.4%)
Dec 2016
-$466.00 K
-$415.40 K(-427.3%)
-$465.90 K(+1891.0%)
Sep 2016
-
$126.90 K(+16.7%)
-$23.40 K(-125.5%)
Jun 2016
-
$108.70 K(-138.0%)
$91.60 K(-35.7%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$286.10 K(-1155.7%)
$142.40 K(-72.4%)
Dec 2015
$515.10 K(-1014.9%)
$27.10 K(-88.8%)
$515.20 K(-32.3%)
Sep 2015
-
$241.90 K(+51.7%)
$760.90 K(+124.1%)
Jun 2015
-
$159.50 K(+84.0%)
$339.60 K(-272.9%)
Mar 2015
-
$86.70 K(-68.2%)
-$196.40 K(+248.2%)
Dec 2014
-$56.30 K(-105.0%)
$272.80 K(-252.1%)
-$56.40 K(-111.3%)
Sep 2014
-
-$179.40 K(-52.4%)
$500.40 K(-42.9%)
Jun 2014
-
-$376.50 K(-266.1%)
$876.30 K(-35.2%)
Mar 2014
-
$226.70 K(-72.7%)
$1.35 M(+19.4%)
Dec 2013
$1.13 M(-281.5%)
$829.60 K(+322.2%)
$1.13 M(+271.9%)
Sep 2013
-
$196.50 K(+96.7%)
$304.50 K(-314.4%)
Jun 2013
-
$99.90 K(+1436.9%)
-$142.00 K(-71.0%)
Mar 2013
-
$6500.00(+306.3%)
-$489.60 K(-21.6%)
Dec 2012
-$624.00 K(+19.7%)
$1600.00(-100.6%)
-$624.10 K(+15.0%)
Sep 2012
-
-$250.00 K(+0.9%)
-$542.80 K(-19.2%)
Jun 2012
-
-$247.70 K(+93.5%)
-$671.70 K(+20.4%)
Mar 2012
-
-$128.00 K(-254.4%)
-$557.90 K(+7.0%)
Dec 2011
-$521.50 K(-60.2%)
$82.90 K(-121.9%)
-$521.50 K(-12.5%)
Sep 2011
-
-$378.90 K(+183.0%)
-$595.70 K(-6.1%)
Jun 2011
-
-$133.90 K(+46.2%)
-$634.30 K(-45.4%)
Mar 2011
-
-$91.60 K(-1152.9%)
-$1.16 M(-11.3%)
Dec 2010
-$1.31 M(-25.9%)
$8700.00(-102.1%)
-$1.31 M(-17.9%)
Sep 2010
-
-$417.50 K(-37.0%)
-$1.60 M(+5.7%)
Jun 2010
-
-$662.20 K(+175.6%)
-$1.51 M(+13.6%)
Mar 2010
-
-$240.30 K(-13.3%)
-$1.33 M(-24.8%)
Dec 2009
-$1.77 M(+92.5%)
-$277.30 K(-16.4%)
-$1.77 M(-2.6%)
Sep 2009
-
-$331.70 K(-31.0%)
-$1.82 M(+7.3%)
Jun 2009
-
-$480.70 K(-29.3%)
-$1.69 M(+20.2%)
Mar 2009
-
-$679.90 K(+109.3%)
-$1.41 M(+53.2%)
Dec 2008
-$919.40 K(+202.8%)
-$324.80 K(+56.3%)
-$919.50 K(+54.6%)
Sep 2008
-
-$207.80 K(+6.1%)
-$594.70 K(+53.7%)
Jun 2008
-
-$195.80 K(+2.5%)
-$386.90 K(+102.5%)
Mar 2008
-
-$191.10 K
-$191.10 K
Dec 2007
-$303.60 K
-
-

FAQ

  • What is OptimizeRx annual cash flow from operations?
  • What is the all time high annual CFO for OptimizeRx?
  • What is OptimizeRx annual CFO year-on-year change?
  • What is OptimizeRx quarterly cash flow from operations?
  • What is the all time high quarterly CFO for OptimizeRx?
  • What is OptimizeRx quarterly CFO year-on-year change?
  • What is OptimizeRx TTM cash flow from operations?
  • What is the all time high TTM CFO for OptimizeRx?
  • What is OptimizeRx TTM CFO year-on-year change?

What is OptimizeRx annual cash flow from operations?

The current annual CFO of OPRX is -$7.24 M

What is the all time high annual CFO for OptimizeRx?

OptimizeRx all-time high annual cash flow from operations is $10.65 M

What is OptimizeRx annual CFO year-on-year change?

Over the past year, OPRX annual cash flow from operations has changed by -$17.89 M (-167.95%)

What is OptimizeRx quarterly cash flow from operations?

The current quarterly CFO of OPRX is $1.79 M

What is the all time high quarterly CFO for OptimizeRx?

OptimizeRx all-time high quarterly cash flow from operations is $4.08 M

What is OptimizeRx quarterly CFO year-on-year change?

Over the past year, OPRX quarterly cash flow from operations has changed by $0.00 (0.00%)

What is OptimizeRx TTM cash flow from operations?

The current TTM CFO of OPRX is -$1.57 M

What is the all time high TTM CFO for OptimizeRx?

OptimizeRx all-time high TTM cash flow from operations is $10.65 M

What is OptimizeRx TTM CFO year-on-year change?

Over the past year, OPRX TTM cash flow from operations has changed by $0.00 (0.00%)